Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Nuclear Medicine

  Free Subscription


20.04.2026

1 AJNR Am J Neuroradiol
5 Ann Nucl Med
1 Circ Cardiovasc Imaging
4 Clin Nucl Med
2 Hum Brain Mapp
5 J Nucl Cardiol
4 J Nucl Med
2 Neurology
2 Nuklearmedizin
1 Phys Med Biol
1 Semin Nucl Med


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJNR Am J Neuroradiol

  1. EBANI EJ, Yadav D, Knight-Greenfield A, Gardella J, et al
    Cross-Platform Concordance of Quantitative Amyloid PET Z-Scores in a Real-World Clinical Cohort of Patients with Cognitive Impairment and Suspected Alzheimer Disease.
    AJNR Am J Neuroradiol. 2026 Apr 15:ajnr.A9354. doi: 10.3174/ajnr.A9354.
    PubMed         Abstract available


    Ann Nucl Med

  2. SONG Q, Li M
    Letter to the editor: [(18)F]SMBT-1 PET quantification - methodological considerations and future directions.
    Ann Nucl Med. 2026 Apr 17. doi: 10.1007/s12149-026-02203.
    PubMed        

  3. TAKAHASHI K, Yamamoto S, Sasaki D, Iwamura T, et al
    Visceral technetium-99 m-labeled pyrophosphate uptake in patients with wild-type transthyretin cardiac amyloidosis.
    Ann Nucl Med. 2026 Apr 16. doi: 10.1007/s12149-026-02174.
    PubMed        

  4. EL BARKAOUI AE, Scheiber C, Thobois S, Buchert R, et al
    Performance of CT-guided spatial normalization for semi-quantification of dopamine transporter SPECT and detection of nigrostriatal degeneration.
    Ann Nucl Med. 2026 Apr 13. doi: 10.1007/s12149-026-02204.
    PubMed        

  5. IBRAHIM EA
    PSMA PET/CT imaging for biochemical recurrence in prostate cancer: can it replace conventional imaging and guide salvage therapy?
    Ann Nucl Med. 2026 Apr 13. doi: 10.1007/s12149-026-02192.
    PubMed        

  6. RUAN T
    The 68Ga-PSMA-11 PET/CT PRIMARY score for predicting pathological upgrading in ISUP grade group 1 prostate cancer: Methodological considerations and future directions.
    Ann Nucl Med. 2026 Apr 11. doi: 10.1007/s12149-026-02207.
    PubMed        


    Circ Cardiovasc Imaging

  7. SPERRY BW, O'Keefe E, Burgett EV, Hutt E, et al
    Kinetics of Technetium-Labeled Cardiac Amyloid Radionuclide Imaging.
    Circ Cardiovasc Imaging. 2026 Apr 10:e019371.
    PubMed         Abstract available


    Clin Nucl Med

  8. EL YAAGOUBI Y, Prunier-Aesch C, Philippe L
    18F-NaF PET/CT in "Shin Splint" Syndrome.
    Clin Nucl Med. 2026 Apr 10. doi: 10.1097/RLU.0000000000006483.
    PubMed         Abstract available

  9. ENGIN MN, Surer Budak E, Arcay Ozturk A
    Incidental Intracranial Schwannoma With High 68Ga-PSMA Uptake on PET/CT.
    Clin Nucl Med. 2026 Apr 10. doi: 10.1097/RLU.0000000000006449.
    PubMed         Abstract available

  10. SABER TANHA A, Elahifard H, Saberifar M, Raeisi N, et al
    Superior Diagnostic Performance of (6)(8)Ga-FAPI PET/CT Compared With (6)(8)Ga-DOTATATE PET/CT in Medullary Thyroid Carcinoma.
    Clin Nucl Med. 2026 Apr 10. doi: 10.1097/RLU.0000000000006455.
    PubMed         Abstract available

  11. SHEN S, Liu B, Xin J, Pan S, et al
    Persistent Mullerian Duct Syndrome on 18F-FDG PET/CT.
    Clin Nucl Med. 2026 Apr 10. doi: 10.1097/RLU.0000000000006433.
    PubMed         Abstract available


    Hum Brain Mapp

  12. BATTISTELLA G, Simonyan K
    Linking GABAergic and Dopaminergic Neurotransmission: Effects on Neural Activity During Human Speech Control.
    Hum Brain Mapp. 2026;47:e70531.
    PubMed         Abstract available

  13. MOON J, Kim S, Chung H, Jang I, et al
    Cyclic 2.5D Perceptual Loss for Cross-Modal 3D Medical Image Synthesis: T1w MRI to Tau PET.
    Hum Brain Mapp. 2026;47:e70508.
    PubMed         Abstract available


    J Nucl Cardiol

  14. HORGAN SJ, Heller GV, Maddahi J, Bateman TM, et al
    Diagnostic performance of F-18 flurpiridaz in women: A sub-study of the Aurora Phase 3 trial.
    J Nucl Cardiol. 2026;58:102640.
    PubMed         Abstract available

  15. PAUNET T, Kucharczak F, Dubois J, Huet F, et al
    Association of colchicine use with myocardial perfusion reserve after myocardial infarction: An ancillary analysis of the COLD-MI trial.
    J Nucl Cardiol. 2026;58:102647.
    PubMed         Abstract available

  16. SCHINDLER TH, Ozkan E
    Moving toward positron emission tomography-determined phenotyping of coronary microvascular dysfunction?
    J Nucl Cardiol. 2026;58:102620.
    PubMed        

  17. VEERANNA V, Campisi R
    Fluorine-18 flurpiridaz positron emission tomography myocardial perfusion imaging in women: A new radiotracer for improving coronary artery disease detection?
    J Nucl Cardiol. 2026;58:102673.
    PubMed        

  18. ALI FZ, Packard RRS
    Protocol optimization for (18)F-flurpiridaz positron emission tomography myocardial perfusion imaging to enhance clinical workflow.
    J Nucl Cardiol. 2026;58:102674.
    PubMed        


    J Nucl Med

  19. BRUSA I, Santoro M, Dall'Olio D, Fuso GA, et al
    Dynamic Total-Body PET Imaging Unfolds [(11)C]Choline Kinetics and Dosimetry in Primary Hyperparathyroidism.
    J Nucl Med. 2026 Apr 16:jnumed.125.270518. doi: 10.2967/jnumed.125.270518.
    PubMed         Abstract available

  20. UNTERRAINER LM, Ndlovu H, Hope TA, Unterrainer M, et al
    Prognostic Value of PSMA PET-Derived Tumor Burden Stratification in Metastatic Hormone-Sensitive Prostate Cancer.
    J Nucl Med. 2026 Apr 16:jnumed.125.271598. doi: 10.2967/jnumed.125.271598.
    PubMed         Abstract available

  21. STANZEL S, Nazerani-Zemann T, Weitzer F, Plhak E, et al
    Prospective Head-to-Head Comparison of Fibroblast Imaging with [(68)Ga]Ga-FAPI-46 PET/CT and [(18)F]FDG PET/CT in Unclear Hepatic Lesions.
    J Nucl Med. 2026 Apr 16:jnumed.125.271597. doi: 10.2967/jnumed.125.271597.
    PubMed         Abstract available

  22. METSER U, Bauman G, Rashid M, Mirshahvalad SA, et al
    Utility of PSMA PET/CT After an Initial Negative Scan: Results from a Prospective Multicenter PSMA PET Registry.
    J Nucl Med. 2026 Apr 16:jnumed.126.272204. doi: 10.2967/jnumed.126.272204.
    PubMed         Abstract available


    Neurology

  23. YOO HS, Kim HK, Park M, Ahn SJ, et al
    Functional Reorganization of Corticostriatal Connectivity Across the Degree of Nigrostriatal Degeneration in Parkinson Disease.
    Neurology. 2026;106:e214812.
    PubMed         Abstract available

  24. SEWELL KR, Solis-Urra P, Huang H, Karikari TK, et al
    Cognitive and Brain Reserve as Modifiers of Early Alzheimer Disease-Related Cognitive Vulnerability.
    Neurology. 2026;106:e214833.
    PubMed         Abstract available


    Nuklearmedizin

  25. LEONTEV A, Lokhova A, Khalimon A, Khodzhibekova M, et al
    Impact assessment of [18F]FDG PET/CT in predicting EGFR gene mutation status in patients with lung adenocarcinoma using recovery coefficient-based correction of semi-quantitative and volume-based PET metrics.
    Nuklearmedizin. 2026 Apr 13. doi: 10.1055/a-2777-2278.
    PubMed         Abstract available

  26. ROGASCH JMM, Amthauer H, Kluge R, Bares R, et al
    DGN procedural guideline for bone scintigraphy with SPECT and SPECT/CT in children and adolescents.
    Nuklearmedizin. 2026 Apr 10. doi: 10.1055/a-2784-7659.
    PubMed         Abstract available


    Phys Med Biol

  27. PAN B, Pan J, Gan K, Shen Y, et al
    Few shots transfer learning for universal SPECT denoising across diverse acquisition protocols.
    Phys Med Biol. 2026 Apr 13. doi: 10.1088/1361-6560.
    PubMed         Abstract available


    Semin Nucl Med

  28. BULTEN BF, Slart RHJA, Glaudemans AWJM, Hess S, et al
    Standardization of infection [(18)F]FDG-PET/CT imaging protocols and reporting criteria.
    Semin Nucl Med. 2026 Apr 11:S0001-2998(26)00081.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum